Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1916 1
1922 1
1927 1
1938 1
1940 1
1944 1
1945 1
1946 2
1947 2
1948 2
1951 1
1953 1
1954 2
1955 1
1956 1
1958 1
1961 1
1963 2
1964 3
1965 1
1966 3
1967 9
1968 4
1969 3
1970 1
1971 2
1972 5
1973 1
1975 1
1978 1
1979 1
1981 3
1983 1
1984 4
1985 1
1986 2
1987 3
1988 4
1989 8
1990 1
1991 5
1992 5
1993 3
1994 3
1995 4
1996 1
1997 3
1998 4
1999 6
2000 3
2001 4
2002 7
2003 8
2004 7
2005 6
2006 8
2007 9
2008 10
2009 12
2010 13
2011 11
2012 10
2013 11
2014 8
2015 10
2016 7
2017 9
2018 7
2019 11
2020 10
2021 13
2022 10
2023 3
Text availability
Article attribute
Article type
Publication date

Search Results

309 results
Results by year
Filters applied: . Clear all
Page 1
Initial Management of Seizure in Adults.
Smith PEM. Smith PEM. N Engl J Med. 2021 Jul 15;385(3):251-263. doi: 10.1056/NEJMcp2024526. N Engl J Med. 2021. PMID: 34260837 Review. No abstract available.
The SANAD II study of the effectiveness and cost-effectiveness of valproate versus levetiracetam for newly diagnosed generalised and unclassifiable epilepsy: an open-label, non-inferiority, multicentre, phase 4, randomised controlled trial.
Marson A, Burnside G, Appleton R, Smith D, Leach JP, Sills G, Tudur-Smith C, Plumpton C, Hughes DA, Williamson P, Baker GA, Balabanova S, Taylor C, Brown R, Hindley D, Howell S, Maguire M, Mohanraj R, Smith PE; SANAD II collaborators. Marson A, et al. Among authors: smith pe. Lancet. 2021 Apr 10;397(10282):1375-1386. doi: 10.1016/S0140-6736(21)00246-4. Lancet. 2021. PMID: 33838758 Free PMC article. Clinical Trial.
The SANAD II study of the effectiveness and cost-effectiveness of levetiracetam, zonisamide, or lamotrigine for newly diagnosed focal epilepsy: an open-label, non-inferiority, multicentre, phase 4, randomised controlled trial.
Marson A, Burnside G, Appleton R, Smith D, Leach JP, Sills G, Tudur-Smith C, Plumpton C, Hughes DA, Williamson P, Baker GA, Balabanova S, Taylor C, Brown R, Hindley D, Howell S, Maguire M, Mohanraj R, Smith PE; SANAD II collaborators. Marson A, et al. Among authors: smith pe. Lancet. 2021 Apr 10;397(10282):1363-1374. doi: 10.1016/S0140-6736(21)00247-6. Lancet. 2021. PMID: 33838757 Free PMC article. Clinical Trial.
Editors' commentary.
Smith PEM, Fuller GN. Smith PEM, et al. Pract Neurol. 2022 Dec;22(6):445. doi: 10.1136/pn-2022-003637. Pract Neurol. 2022. PMID: 36450376 No abstract available.
Neurology teambuilding event.
Smith PEM, Pierri M. Smith PEM, et al. Pract Neurol. 2022 Dec;22(6):472-477. doi: 10.1136/practneurol-2022-003358. Epub 2022 May 24. Pract Neurol. 2022. PMID: 35609984
The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trial.
Marson AG, Al-Kharusi AM, Alwaidh M, Appleton R, Baker GA, Chadwick DW, Cramp C, Cockerell OC, Cooper PN, Doughty J, Eaton B, Gamble C, Goulding PJ, Howell SJ, Hughes A, Jackson M, Jacoby A, Kellett M, Lawson GR, Leach JP, Nicolaides P, Roberts R, Shackley P, Shen J, Smith DF, Smith PE, Smith CT, Vanoli A, Williamson PR; SANAD Study group. Marson AG, et al. Among authors: smith pe. Lancet. 2007 Mar 24;369(9566):1016-26. doi: 10.1016/S0140-6736(07)60461-9. Lancet. 2007. PMID: 17382828 Free PMC article. Clinical Trial.
The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trial.
Marson AG, Al-Kharusi AM, Alwaidh M, Appleton R, Baker GA, Chadwick DW, Cramp C, Cockerell OC, Cooper PN, Doughty J, Eaton B, Gamble C, Goulding PJ, Howell SJ, Hughes A, Jackson M, Jacoby A, Kellett M, Lawson GR, Leach JP, Nicolaides P, Roberts R, Shackley P, Shen J, Smith DF, Smith PE, Smith CT, Vanoli A, Williamson PR; SANAD Study group. Marson AG, et al. Among authors: smith pe. Lancet. 2007 Mar 24;369(9566):1000-15. doi: 10.1016/S0140-6736(07)60460-7. Lancet. 2007. PMID: 17382827 Free PMC article. Clinical Trial.
Lamotrigine versus levetiracetam or zonisamide for focal epilepsy and valproate versus levetiracetam for generalised and unclassified epilepsy: two SANAD II non-inferiority RCTs.
Marson AG, Burnside G, Appleton R, Smith D, Leach JP, Sills G, Tudur-Smith C, Plumpton CO, Hughes DA, Williamson PR, Baker G, Balabanova S, Taylor C, Brown R, Hindley D, Howell S, Maguire M, Mohanraj R, Smith PE. Marson AG, et al. Among authors: smith pe. Health Technol Assess. 2021 Dec;25(75):1-134. doi: 10.3310/hta25750. Health Technol Assess. 2021. PMID: 34931602 Free article. Clinical Trial.
Editors' commentary.
Smith PE, Fuller GN. Smith PE, et al. Pract Neurol. 2022 Oct;22(5):341. doi: 10.1136/pn-2022-003579. Pract Neurol. 2022. PMID: 36162859 No abstract available.
Management of suspected viral encephalitis in adults--Association of British Neurologists and British Infection Association National Guidelines.
Solomon T, Michael BD, Smith PE, Sanderson F, Davies NW, Hart IJ, Holland M, Easton A, Buckley C, Kneen R, Beeching NJ; National Encephalitis Guidelines Development and Stakeholder Groups. Solomon T, et al. Among authors: smith pe. J Infect. 2012 Apr;64(4):347-73. doi: 10.1016/j.jinf.2011.11.014. Epub 2011 Nov 18. J Infect. 2012. PMID: 22120595
309 results